First Header Logo Second Header Logo

Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.

Wareham LK, Dordea AC, Schleifer G, Yao V, Batten A, Fei F, Mertz J, Gregory-Ksander M, Pasquale LR, Buys ES, Sappington RM. Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration. Neurobiol Dis. 2019 01; 121:65-75.

View in: PubMed